1. Home
  2. CVKD vs ATIF Comparison

CVKD vs ATIF Comparison

Compare CVKD & ATIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • ATIF
  • Stock Information
  • Founded
  • CVKD 2022
  • ATIF 2015
  • Country
  • CVKD United States
  • ATIF China
  • Employees
  • CVKD N/A
  • ATIF N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • ATIF Professional Services
  • Sector
  • CVKD Health Care
  • ATIF Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • ATIF Nasdaq
  • Market Cap
  • CVKD 8.2M
  • ATIF 11.2M
  • IPO Year
  • CVKD 2023
  • ATIF 2019
  • Fundamental
  • Price
  • CVKD $0.43
  • ATIF $0.97
  • Analyst Decision
  • CVKD Strong Buy
  • ATIF
  • Analyst Count
  • CVKD 2
  • ATIF 0
  • Target Price
  • CVKD $3.50
  • ATIF N/A
  • AVG Volume (30 Days)
  • CVKD 71.3K
  • ATIF 5.5K
  • Earning Date
  • CVKD 08-12-2024
  • ATIF 06-14-2024
  • Dividend Yield
  • CVKD N/A
  • ATIF N/A
  • EPS Growth
  • CVKD N/A
  • ATIF N/A
  • EPS
  • CVKD N/A
  • ATIF N/A
  • Revenue
  • CVKD N/A
  • ATIF $500,000.00
  • Revenue This Year
  • CVKD N/A
  • ATIF N/A
  • Revenue Next Year
  • CVKD N/A
  • ATIF N/A
  • P/E Ratio
  • CVKD N/A
  • ATIF N/A
  • Revenue Growth
  • CVKD N/A
  • ATIF N/A
  • 52 Week Low
  • CVKD $0.36
  • ATIF $0.65
  • 52 Week High
  • CVKD $2.17
  • ATIF $2.00
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 40.00
  • ATIF 58.53
  • Support Level
  • CVKD $0.43
  • ATIF $0.85
  • Resistance Level
  • CVKD $0.49
  • ATIF $0.96
  • Average True Range (ATR)
  • CVKD 0.02
  • ATIF 0.07
  • MACD
  • CVKD -0.00
  • ATIF 0.01
  • Stochastic Oscillator
  • CVKD 0.17
  • ATIF 70.53

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About ATIF ATIF Holdings Limited

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: